Suchith Shetty

Suchith Shetty

Auto-generated profile, based on publicly available information

Suchith Shetty

Research & Innovation Department, Southern Health NHS Foundation Trust, Southampton, United Kingdom

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Women's Health
Verified
Journal Article
Open access
PDF file
GDGayathri Delanerolle
Gayathri Delanerolle
XYXuzhi Yang
Xuzhi Yang
SSSuchith Shetty
Suchith Shetty
VRVanessa Raymont
Vanessa Raymont
ASAshish Shetty
Ashish Shetty
JSJian Qing Shi
Jian Qing Shi
To evaluate and holistically treat the mental health sequelae and potential psychiatric comorbidities associated with obstetric and gynaecological conditions, it is important to optimize patient care, ensure efficient use of limited resources and improve health-economic models. Artificial intelligence applications could assist in achieving the above. The World Health Organization and global healthcare systems have already recognized the use of artificial intelligence technologies to address ‘system gaps’ and automate some of the more cumbersome tasks to optimize clinical services and reduce health inequalities. Currently, both mental health and obstetric and gynaecological services independently use artificial intelligence applications. Thus, suitable solutions are shared between mental health and obstetric and gynaecological clinical practices, independent of one another. Although, to address complexities with some patients who may have often interchanging sequelae with mental health and obstetric and gynaecological illnesses, ‘holistically’ developed artificial intelligence applications could be useful. Therefore, we present a rapid review to understand the currently available artificial intelligence applications and research into multi-morbid conditions, including clinical trial-based validations. Most artificial intelligence applications are intrinsically data-driven tools, and their validation in healthcare can be challenging as they require large-scale clinical trials. Furthermore, most artificial intelligence applications use rate-limiting mock data sets, which restrict their applicability to a clinical population. Some researchers may fail to recognize the randomness in the data generating processes in clinical care from a statistical perspective with a potentially minimal representation of a population, limiting their applicability within a real-world setting. However, novel, innovative trial designs could pave the way to generate better data sets that are generalizable to the entire global population. A collaboration between artificial intelligence and statistical models could be developed and deployed with algorithmic and domain interpretability to achieve this. In addition, acquiring big data sets is vital to ensure these artificial intelligence applications provide the highest accuracy within a real-world setting, especially when used as part of a clinical diagnosis or treatment.

17 January 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
PPPeter Phiri
Peter Phiri
HCHeitor Cavalini
Heitor Cavalini
SSSuchith Shetty
Suchith Shetty
GDGayathri Delanerolle
Gayathri Delanerolle
The National Health Service (NHS), the health care system of the United Kingdom, is one of the largest health care entities in the world and has been successfully serving the UK population for decades. The NHS is also the fourth-largest employer globally. True to its reputation, some of the most modern and technically advanced medical services are available in the United Kingdom. However, between the acute, primary, secondary, and tertiary care providers of the NHS, there needs to be seamless integration and interoperability to provide timely holistic care to patients at a national level. Various efforts have been taken and programs launched since 2002 to achieve digital transformation in the NHS but with partial success rates. As it is important to understand a problem before trying to solve it, in this paper, we focus on tools used to assess the digital maturity of NHS trusts and organizations. Additionally, we aim to present the impact of ongoing transformation attempts on secondary services, particularly mental health. This paper considered the literature on digital maturity and performed a rapid review of currently available tools to measure digital maturity. We have performed a multivocal literature review that included white papers and web-based documents in addition to peer-reviewed literature. Further, the paper also provides a perspective of the ground reality from a mental health service provider’s point of view. Assessment tools adopted from the global market, later modified and tailor-made to suit local preferences, are currently being used. However, there is a need for a robust framework that assesses status, allows target setting, and tracks progress across diverse providers.

27 February 2022 in JMIR Preprints
Verified
Preprint
Open access
PPPeter Phiri
Peter Phiri
HCHeitor Cavalini
Heitor Cavalini
SSSuchith Shetty
Suchith Shetty
GDGayathri Delanerolle
Gayathri Delanerolle
UNSTRUCTURED The National Health Service (NHS), the healthcare system of the UK, is one of the largest healthcare entities in the world and has been successfully serving the UK population for decades. The NHS is also the 4th largest employer globally. True to its reputation, some of the most modern and technically advanced medical services are available in the UK. However, between the acute, primary, secondary, and tertiary care providers of NHS, there needs to be seamless integration and interoperability to provide timely, holistic care to the patients at a national level. Various efforts have been taken and programs launched since 2002 to achieve digital transformation in NHS, but with partial success rates. As it is important to completely understand a problem before trying to solve the problem, in this article, we focus on tools used to assess the digital maturity of NHS trusts and organizations. Assessment tools adopted from the global market, later modified and tailor-made to suit local preferences are currently being used. But there is a need for a robust framework that assesses status, allows target setting, and tracks progress across diverse providers.

4 March 2022 in medRxiv
Verified
Preprint
Open access
PDF file
ASAshish Shetty
Ashish Shetty
GDGayathri Delanerolle
Gayathri Delanerolle
YZYutian Zeng
Yutian Zeng
JSJian Qing Shi
Jian Qing Shi
RERawan Ebrahim
Rawan Ebrahim
RBRobert Brownstone
Robert Brownstone
Importance: Pain is a silent global epidemic impacting approximately a third of the population. Pharmacological and surgical interventions are primary modes of treatment. Cognitive/behavioural management approaches and interventional pain management strategies are approaches that have been used to assist with the management of chronic pain. Accurate data collection and reporting treatment outcomes are vital to addressing the challenges faced. In light of this, we conducted a systematic evaluation of the current digital application landscape within chronic pain medicine. Objective: The primary objective was to consider the prevalence of digital application usage for chronic pain management. These digital applications included mobile apps, web apps, and chatbots. Data Sources: We conducted searches on PubMed and ScienceDirect for studies that were published between 1st January 1990 and 1st January 2021. Study Selection: Our review included studies that involved the use of digital applications for chronic pain conditions. There were no restrictions on the country in which the study was conducted. Only studies that were peer-reviewed and published in English were included. Four reviewers had assessed the eligibility of each study against the inclusion/exclusion criteria. Out of the 84 studies that were initially identified, 38 were included in the systematic review. Data Extraction and Synthesis: The AMSTAR guidelines were used to assess data quality. This assessment was carried out by 3 reviewers. The data were pooled using a random-effects model. Main Outcome(s) and Measure(s): Before data collection began, the primary outcome was to report on the prevalence of digital application usage for chronic pain conditions. We also recorded the type of digital application studied (e.g. mobile application, web application) and, where the data was available, the prevalence of pain intensity, pain inferences, depression, anxiety, and fatigue. Results: 38 studies were included in the systematic review and 22 studies were included in the meta-analysis. The digital interventions were categorised to web and mobile applications and chatbots, with pooled prevalence of 0.22 (95% CI −0.16, 0.60), 0.30 (95% CI 0.00, 0.60) and −0.02 (95% CI −0.47, 0.42) respectively. Pooled standard mean differences for symptomatologies of pain intensity, depression, and anxiety symptoms were 0.25 (95% CI 0.03, 0.46), 0.30 (95% CI 0.17, 0.43) and 0.37 (95% CI 0.05, 0.69) respectively. A sub-group analysis was conducted on pain intensity due to the heterogeneity of the results (I 2 =82.86%; p=0.02). After stratifying by country, we found that digital applications were more likely to be effective in some countries (e.g. USA, China) than others (e.g. Ireland, Norway). Conclusions and Relevance: The use of digital applications in improving pain-related symptoms shows promise, but further clinical studies would be needed to develop more robust applications.

10 March 2022 in JMIR Preprints
Verified
Preprint
Open access
GDGayathri Delanerolle
Gayathri Delanerolle
SSSuchith Shetty
Suchith Shetty
HCHeitor Cavalini
Heitor Cavalini
PPPeter Phiri
Peter Phiri
UNSTRUCTURED Background: Mental illness has a high disease burden within the UK, attributing to 22.8% in comparison to Cancer (15.9%) and Cardiovascular disease (16.2%). Costs of mental illness in England have been evaluated at £105.2 billion each year. This burden could be reduced by effective use of Electronic Health Records that could provide vital information around diagnosis, prevalence and incidence of mental illnesses to better understand the nuances of clinical and patient reported outcomes. To better evaluate some of the technical methods that could be better used, we explored Natural Language Processing. Objective: Our primary objective was to evaluate the use of Natural Language Processing methods and it’s association with unstructured EHR text data from U.K.-CRIS. Methods: We used a descriptive methodology to demonstrate the use of NLP and validated the method using Southern Health NHS Trust electronic health data. Conclusions: We can conclude that the method used is suitable for the mental health service. However, to generalize our findings, a wider validation study across mental health organisations in the UK would be required.